The CDK inhibitor p21(WAF1/Cip1) is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells

Oncogene

Volumn 13, Issue 10, 1996, Pages 2047-2054

  Billon, Nathalie ^a   Van Grunsven, Leo A ^a   Rudkin, Brian B ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

Cell cycle; Differentiation; E1A; NGF; p21(WAF1 Cip1); p300; PC12

Indexed keywords

CYCLIN DEPENDENT KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CDKN1A PROTEIN, RAT; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; E1A ASSOCIATED P300 PROTEIN; EP300 PROTEIN, RAT; LUCIFERASE; MESSENGER RNA; NERVE GROWTH FACTOR RECEPTOR; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; MITOSIS INHIBITION; NERVE CELL DIFFERENTIATION; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; RAT; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; ANIMAL; CELL STRAIN; DRUG EFFECT; GENE VECTOR; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHEOCHROMOCYTOMA; PHYSIOLOGY;

ANIMALS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; E1A-ASSOCIATED P300 PROTEIN; GENETIC VECTORS; HUMANS; LUCIFERASES; NERVE GROWTH FACTORS; NUCLEAR PROTEINS; PC12 CELLS; PHEOCHROMOCYTOMA; RATS; RECEPTORS, NERVE GROWTH FACTOR; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029658148     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Arany Z, Newsome D, Oldread E, Livingston DM and Eckner R. (1995). Nature, 374, 81-84.
2. Avantaggiati ML, Carbone M, Graessmann A, Nakatani Y, Howard B and Levine AS. (1996). EMBO J., 15, 2236-2248.
3. Bannister AJ and Kouzarides T. (1995). EMBO J., 14, 4790-4795.
4. Boulukos KE and Ziff EB. (1993). Oncogene, 8, 237-248.
5. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ. (1995). Nature, 377, 552-557.
6. Casillas AM, Amaral K, Chegini-Farahani S and Nel AE. (1993). Biochem. J., 290, 545-550.
7. Chao MV and Hempstead BL. (1995). TINS, 18, 321-326.
8. Chomczynsky P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
9. Dai P, Akimaru H, Tanaka Y, Hou D-X, Yasukawa T, Kanei-Ishii C, Takahashi T and Ishii S. (1996). Genes & Dev., 10, 528-540.
10. Datto MB, Yu Y and Wang XF. (1995). J Biol. Chem., 270, 28623-28628.
11. Decker SJ. (1995). J. Biol. Chem., 270, 30841-30844.
12. Dobashi Y, Kudoh T, Matsumine A, Toyoshima K and Akiyama T. (1995). J. Biol. Chem., 270, 23031-23037.
13. Dubois PM, Palmer D, Webb ML, Ledbetter JA and Shapiro RA. (1996). J. Immunol., 156, 1356-1361.
14. Dulic V, Kaufmann WK, Wilson SJ, Tisty TD, Lees E, Harper W, Elledge SJ and Reed SI. (1994). Cell, 76, 1013-1023.
15. Dyson N, Guida P, McCall C. (1992). J. Virol., 66, 4606-4611.
16. Eckner R, Ewen ME, Newsome D, Gerdes M, Decaprio JA, Bentley Lawrence J and Livingston DM. (1994). Genes & Dev., 8, 869-884.
17. Egan C, Jelsma TN, Howe A, Bayley ST, Ferguson B and Branton PE. (1988). Mol. Cell. Biol., 8, 3955-3959.
18. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817-825.
19. El-Deiry WS, Tokino T, Waldman T, Ollner JD, Velculescu VE, Burell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW and Vogelstein B. (1995). Cancer Res., 55, 2910-2919.
20. Graham FL and van der Eb AJ. (1973). Virology, 52, 456-467.
21. Guo K, Wang J, Andres V, Smith RC and Walsh K. (1995). Mol. Cell. Biol., 15, 3823-3829.
22. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D and Lasser AB. (1995). Science, 267, 1018-1021.
23. Harper JW, Elledge SJ and Wei N. (1995). Mol. Biol. Cell, 6, 387-400.
24. Heasley LE, Benedict S, Gleavy J and Johnson GL. (1991). Cell Regulation, 2, 479-489.
25. Hunter T and Pines J. (1994). Cell, 79, 573-582.
26. Jiang H, Lin J, Su Z, Collart FR, Huberman E and Fisher PB. (1994). Oncogene, 9, 3397-3406.
27. Kaplan DR and Stephens RM. (1994). J. Neurobiol., 25, 1404-1417.
28. Leevers SJ and Marshall CJ. (1992). EMBO J., 11, 569-573.
29. Liu M, Lee M-H, Cohen M, Bommakanti M and Freedman LP. (1996). Genes & Dev., 10, 142-153.
30. Lundblad JR, Kwok RPS, Laurance ME, Harter ML and Goodman RH. (1995). Nature, 374, 83-88.
31. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B and Jacks T. (1995). Genes & Dev., 9, 935-944.
32. Marshall CJ. (1995). Cell, 80, 179-185.
33. Missero C, Filvaroff E and Dotto GP. (1991). Proc. Natl. Acad. Sci. USA, 88, 3489-3493.
34. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM and Dotto GP. (1995). Proc. Natl. Acad. Sci. USA, 92, 5451-5455.
35. Moran E. (1993). Cur. Opin. Gen. Dev., 3, 63-70.
36. Nakajima T, Fukamizu A, Takahashi J, Gage FH, Fisher T, Blenis J and Montminy MR. (1996). Cell, 86, 465-474.
37. Oelgeschlager M, Janknecht R, Krieg J, Schreck S and Luscher B. (1996). EMBO J., 15, 2771-2780.
38. Parker SB, Eichele G, Zhang P, Rawis A, Sands AT, Bradley A, Olson EN, Harper JW and Elledge SJ. (1995). Science, 267, 1024-1027.
39. Rabin SJ, Cleghon V and Kaplan DR. (1993). Mol. Cell. Biol., 13, 2203-2213.
40. Rudkin BB, Lazarovici P, Levi B-Z, Abe Y, Fujita K and Guroff G. (1989). EMBO J., 8, 3319-3325.
41. Savatier P, Lapillone H, van Grunsven LA, Rudkin BB and Samarut J. (1996). Oncogene, 12, 309-322.
42. Sherr CJ. (1994). Cell, 79, 551-555.
43. Simpson DL, Dickens G, Doll S, Koizumi S, Tocco M, Okuda O, Oshima M, Rudkin BB, Brightman M and Guroff G. (1991). J Neurosci Res., 28, 486-496.
44. Slack RS, Craig J, Costa S and McBurney MW. (1995). Oncogene, 10, 19-25.
45. Smits PHM, de Wit L, van der Eb A and Zantema A. (1996). Oncogene, 12, 1529-1535.
46. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA and El-Houseini ME. (1994). Oncogene, 9, 3389-3396.
47. Traverse S, Gomez N, Paterson H, Marshall C and Cohen P. (1992). Biochem. J., 288, 351-355.
48. van Grunsven LA, Thomas A, Urdiales JL, Machenaud S, Choler P, Durand I and Rudkin BB. (1996a). Oncogene, 12, 855-862.
49. van Grunsven LA, Billon N, Savatier P, Thomas A, Urdiales JL and Rudkin BB. (1996b). Oncogene, 12, 1347-1356.
50. Whyte P, Ruley HE and Harlow E. (1988). J. Virol., 62, 257-265.
51. Xing J, Ginty DD and Greenberg ME. (1996). Science, 273, 959-963.
52. Yan G-Z and Ziff EB. (1995). J. Neurosci., 15, 6200-6212.
53. Zeng X and El-Deiry WS. (1996). Oncogene, 12, 1557-1564.